{"nctId":"NCT01155999","briefTitle":"Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.","startDateStruct":{"date":"2008-12"},"conditions":["Purulent Bacterial Conjunctivitis"],"count":286,"armGroups":[{"label":"T1225","type":"EXPERIMENTAL","interventionNames":["Drug: T1225"]},{"label":"Tobramycin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Tobramycin"]}],"interventions":[{"name":"T1225","otherNames":[]},{"name":"Tobramycin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age ≥ one day of life and ≤ 18 years\n* Purulent bacterial conjunctivitis","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Day","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Primary Efficacy Variable Was Clinical Cure in the Worse Eye on Day 3","description":"Clinical cure was defined as a score 0 for bulbar conjunctival injection (evaluated using a 4 point ordinal scale) and a score 0 for conjunctival purulent discharge (evaluated using a 4 point ordinal scale).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":146},"commonTop":[]}}}